The field of cancer treatment research has witnessed considerable advancements over recent years, with certain groundbreaking developments catching the public's attention due to their potential impact on patient care and treatment efficacy. Among these developments is the news from OBI Pharma,
Telemedicine leadership structures within health systems have significantly evolved since the COVID-19 pandemic, reflecting a shift towards a more centralized approach in digital health strategies. Organizations like OSF Healthcare, the University of Pittsburgh Medical Center (UPMC), and West
Epic Systems Corporation has solidified its status as the leader in the U.S. hospital EHR market, making considerable strides against Oracle Health in 2025. Epic increased its market share to 42.3%, up from 39.1% in the prior year, by adding 176 hospitals with 29,399 beds. This expansion confirms
Eli Lilly has partnered with Alchemab for a significant expansion in amyotrophic lateral sclerosis (ALS) research. This collaboration involves the licensing of ATLX-1282, an innovative antibody that holds promise for future human testing. ALS, a neurodegenerative disease, represents a complex
In a groundbreaking move, the Icahn School of Medicine at Mount Sinai has partnered with OpenAI to give their medical and graduate students, along with certain faculty and staff, access to ChatGPT Edu. This initiative underscores Mount Sinai's commitment to integrating cutting-edge AI
In a bold move to redefine medication accessibility, Petros Pharmaceuticals has announced a strategic pivot toward smart healthcare technology. This transformative shift is focused on expediting the transition of prescription medications to over-the-counter (OTC) availability. By leveraging
